ChanBio Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

ChanBio General Information


Provider of bio-pharmaceutical services designed to treat multiple sclerosis. The company's services provide functional antibody-based modulators active on ion channels and G protein-coupled receptor, enabling healthcare providers to treat autoimmune, cardiovascular, cancer and pain disorders of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Healthcare Services
Drug Discovery
Primary Office
  • Yavne
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ChanBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 28-Nov-2013 Completed Generating Revenue
To view ChanBio’s complete valuation and funding history, request access »

ChanBio Board Members (1)

Name Representing Role Since
Simone Botti Ph.D M Ventures Board Member 000 0000
To view ChanBio’s complete board members history, request access »

ChanBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view ChanBio’s complete investors history, request access »